Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (Ireland)
Pages (from-to)1148-1152
JournalRheumatology
Publication statusPublished - 2007

Cite this